KEGG   Aotus nancymaae (Ma's night monkey): 105723503
Entry
105723503         CDS       T10127                                 
Symbol
CDKN1A
Name
(RefSeq) cyclin-dependent kinase inhibitor 1
  KO
K06625  cyclin-dependent kinase inhibitor 1A
Organism
anan  Aotus nancymaae (Ma's night monkey)
Pathway
anan01522  Endocrine resistance
anan01524  Platinum drug resistance
anan04012  ErbB signaling pathway
anan04066  HIF-1 signaling pathway
anan04068  FoxO signaling pathway
anan04110  Cell cycle
anan04115  p53 signaling pathway
anan04151  PI3K-Akt signaling pathway
anan04218  Cellular senescence
anan04630  JAK-STAT signaling pathway
anan04921  Oxytocin signaling pathway
anan04928  Parathyroid hormone synthesis, secretion and action
anan04934  Cushing syndrome
anan05160  Hepatitis C
anan05161  Hepatitis B
anan05163  Human cytomegalovirus infection
anan05165  Human papillomavirus infection
anan05166  Human T-cell leukemia virus 1 infection
anan05167  Kaposi sarcoma-associated herpesvirus infection
anan05169  Epstein-Barr virus infection
anan05200  Pathways in cancer
anan05202  Transcriptional misregulation in cancer
anan05203  Viral carcinogenesis
anan05205  Proteoglycans in cancer
anan05206  MicroRNAs in cancer
anan05210  Colorectal cancer
anan05211  Renal cell carcinoma
anan05212  Pancreatic cancer
anan05213  Endometrial cancer
anan05214  Glioma
anan05215  Prostate cancer
anan05216  Thyroid cancer
anan05217  Basal cell carcinoma
anan05218  Melanoma
anan05219  Bladder cancer
anan05220  Chronic myeloid leukemia
anan05222  Small cell lung cancer
anan05223  Non-small cell lung cancer
anan05224  Breast cancer
anan05225  Hepatocellular carcinoma
anan05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:anan00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04012 ErbB signaling pathway
    105723503 (CDKN1A)
   04630 JAK-STAT signaling pathway
    105723503 (CDKN1A)
   04066 HIF-1 signaling pathway
    105723503 (CDKN1A)
   04068 FoxO signaling pathway
    105723503 (CDKN1A)
   04151 PI3K-Akt signaling pathway
    105723503 (CDKN1A)
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    105723503 (CDKN1A)
   04115 p53 signaling pathway
    105723503 (CDKN1A)
   04218 Cellular senescence
    105723503 (CDKN1A)
 09150 Organismal Systems
  09152 Endocrine system
   04921 Oxytocin signaling pathway
    105723503 (CDKN1A)
   04928 Parathyroid hormone synthesis, secretion and action
    105723503 (CDKN1A)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    105723503 (CDKN1A)
   05202 Transcriptional misregulation in cancer
    105723503 (CDKN1A)
   05206 MicroRNAs in cancer
    105723503 (CDKN1A)
   05205 Proteoglycans in cancer
    105723503 (CDKN1A)
   05203 Viral carcinogenesis
    105723503 (CDKN1A)
  09162 Cancer: specific types
   05210 Colorectal cancer
    105723503 (CDKN1A)
   05212 Pancreatic cancer
    105723503 (CDKN1A)
   05225 Hepatocellular carcinoma
    105723503 (CDKN1A)
   05226 Gastric cancer
    105723503 (CDKN1A)
   05214 Glioma
    105723503 (CDKN1A)
   05216 Thyroid cancer
    105723503 (CDKN1A)
   05220 Chronic myeloid leukemia
    105723503 (CDKN1A)
   05217 Basal cell carcinoma
    105723503 (CDKN1A)
   05218 Melanoma
    105723503 (CDKN1A)
   05211 Renal cell carcinoma
    105723503 (CDKN1A)
   05219 Bladder cancer
    105723503 (CDKN1A)
   05215 Prostate cancer
    105723503 (CDKN1A)
   05213 Endometrial cancer
    105723503 (CDKN1A)
   05224 Breast cancer
    105723503 (CDKN1A)
   05222 Small cell lung cancer
    105723503 (CDKN1A)
   05223 Non-small cell lung cancer
    105723503 (CDKN1A)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    105723503 (CDKN1A)
   05161 Hepatitis B
    105723503 (CDKN1A)
   05160 Hepatitis C
    105723503 (CDKN1A)
   05163 Human cytomegalovirus infection
    105723503 (CDKN1A)
   05167 Kaposi sarcoma-associated herpesvirus infection
    105723503 (CDKN1A)
   05169 Epstein-Barr virus infection
    105723503 (CDKN1A)
   05165 Human papillomavirus infection
    105723503 (CDKN1A)
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    105723503 (CDKN1A)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    105723503 (CDKN1A)
   01522 Endocrine resistance
    105723503 (CDKN1A)
SSDB
Motif
Pfam: CDI
Other DBs
NCBI-GeneID: 105723503
NCBI-ProteinID: XP_012316988
Ensembl: ENSANAG00000037294
UniProt: A0A2K5F2Y4
LinkDB
Position
Unknown
AA seq 158 aa
MSEQAGDVRPNPSSSKARRCLFGPVDSEQLRRDCDALMAGCIQEARERWNFDFVTETPLE
GDFAWERVRGLGLPKIYLPKGPLGGGRRPGTSPALLQGTAEEDHVDLSLSCTLMPHSRER
PEESPGGPGDSEGRKRRQTSMTDFYHSKRRLIFSKRKP
NT seq 477 nt   +upstreamnt  +downstreamnt
atgtcagaacaggctggggatgtccgtccgaacccatccagcagcaaggcccgccgctgc
ctctttggcccagtggacagcgagcagctgagacgtgactgtgacgcgctgatggcaggc
tgcatccaggaggcccgtgagcgatggaacttcgactttgtcaccgagacaccactggag
ggtgacttcgcctgggagcgtgtgcggggccttggcctgcccaagatctaccttcccaaa
gggcccctgggaggaggcaggcggcctggcacctcgcctgctctgctgcaggggacagcg
gaggaagaccacgtggacctgtcgctgtcttgcacccttatgcctcactcaagggagcgg
cctgaggagtccccaggtggacctggagactctgagggtcgaaaacggcggcagaccagc
atgacagatttctaccactccaaacgccggctgatcttctccaagaggaagccctaa

DBGET integrated database retrieval system